BioCryst Pharmaceutical Inc. (BCRX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Jon P. Stonehouse
Employees:
100
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC 27703
919-859-1302

BioCryst Pharmaceuticals, Inc. is a biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in the pathogenesis of diseases with its focus on therapeutic areas with unmet medical needs. It integrates the disciplines of biology, crystallography, medicinal chemistry and computer modeling to discover and develop small molecule pharmaceuticals through the process known as structure-guided drug design. The company was founded in 1986 and is headquartered in Birmingham, AL.

Data derived from most recent annual or quarterly report
Market Cap 2.629 Billion Shares Outstanding178.87 Million Avg 30-day Volume 2.411 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 18.48 / 3.57 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from BCRX instead.

View recent insider trading info

Funds Holding BCRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BCRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

190 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

196 Thousand total shares from 9 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HUTSON NANCY J

  • Director
65,073 2021-10-15 6

MCKEE AMY E

  • Director
53,333 2021-09-20 2

ABERCROMBIE GEORGE B

  • Director
0 2021-09-15 6

LEE KENNETH B JR

  • Director
24,252 2021-09-13 2

GALSON STEVEN K

  • Director
0 2021-09-01 2

LEVIN ALAN G

  • Director
628 2021-08-31 2

INGRAM ROBERT ALEXANDER

  • Director
77,378 2021-08-31 5

ASELAGE STEVE

  • Director
32,444 2021-08-31 5

HEGGIE THERESA

  • Director
14,794 2021-08-31 5

MILANO VINCENT

  • Director
10,000 2021-07-26 2

SHERIDAN WILLIAM P CHIEF MEDICAL OFFICER

  • Officer
120,764 2021-05-27 4

BARNES ALANE P CHIEF LEGAL OFFICER

  • Officer
292,254 2021-05-11 5

THACKRAY HELEN M. CHIEF R&D OFFICER

  • Officer
  • Director
500,000 2021-03-31 1

JONES MICHAEL L EXEC. DIRECTOR, FINANCE - PAO

  • Officer
5,348 2021-03-18 3

BABU YARLAGADDA S SENIOR VP - DRUG DISCOVERY

  • Officer
183,156 2021-02-19 3

STONEHOUSE JON P PRESIDENT & CEO

  • Officer
  • Director
784,086 2020-12-15 2

SNIECINSKI MEGAN CHIEF BUSINESS OFFICER

  • Officer
0 2020-12-15 1

GAYER CHARLES K VICE PRESIDENT AND CCO

  • Officer
0 2020-12-15 1

DOYLE ANTHONY CHIEF FINANCIAL OFFICER

  • Officer
0 2020-12-15 1

STAAB THOMAS R II SENIOR VICE PRESIDENT AND CFO

  • Officer
0 2020-02-21 0

POWELL LYNNE SENIOR VP - CCO

  • Officer
0 2019-01-25 0

ERCK STANLEY C

  • Director
48,333 2018-11-28 0

COHEN FRED E

  • Director
0 2018-06-20 0

PATEL SANJ K

  • Director
0 2017-05-24 0

BAKER BROS. ADVISORS LP

BAKER BROS. ADVISORS (GP) LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
11,016,695 2016-08-12 0

SANDERS CHARLES A

  • Director
12,971 2016-02-29 0

JENSEN PEDER

  • Director
0 2014-05-02 0

BAKER FELIX

BAKER BROS. INVESTMENTS II, L.P.

BAKER/TISCH INVESTMENTS, LP

667, L.P.

BAKER BROTHERS LIFE SCIENCES LP

14159, L.P.

BAKER BROS. ADVISORS LP

BAKER JULIAN

BAKER BROS. ADVISORS (GP) LLC

BAKER BROS. INVESTMENTS, L.P.

  • 10% Owner
6,699,979 2013-08-01 0

BAKER BROS. ADVISORS (GP) LLC

  • 10% Owner
0 2013-07-01 0

HOROVITZ ZOLA P

  • Director
0 2012-05-23 0

HIGGINS JOHN L

  • Director
0 2012-05-23 0

BAKER BROS ADVISORS LLC

  • 10% Owner
0 2012-04-12 0

LOWREY ROBERT S CONTROLLER, PAO

  • Officer
9,766 2012-03-15 0

MCCULLOUGH DAVID VP

  • Officer
24,124 2012-03-15 0

BAKER BROS. CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
62,407 2011-06-30 0

BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
3,841,124 2011-06-30 0

BIGGAR STEPHEN R

  • Director
0 2011-05-12 0

GRANT STUART SR VP & CFO

  • Officer
57,102 2011-03-16 0

FEATHERINGILL WILLIAM W

  • Director
  • 10% Owner
0 2010-05-13 0

SEIDENBERG BETH C

  • Director
0 2010-05-13 0

MILLS MIKE PRINCIPAL ACCOUNTING OFFICER

  • Officer
0 2010-03-12 0

BAKER BIOTECH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
1,522,015 2009-05-28 0

BAKER / TISCH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
17,241 2009-05-28 0

14159 CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
120,828 2009-05-28 0

DARWIN MICHAEL A PRINCIPAL ACCOUNTING OFFICER

  • Officer
3,048 2008-07-31 0

STEER RANDOLPH C

  • Director
0 2008-05-21 0

BENNETT J CLAUDE CHIEF OPERATING OFFICER

  • Officer
  • Director
0 2008-03-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HUTSON NANCY J - Director

2021-10-19 16:21:49 -0400 2021-10-15 M 15,000 d 0 direct

HUTSON NANCY J - Director

2021-10-19 16:21:49 -0400 2021-10-15 S 105,000 $15.40 d 65,073 direct 1.9539 1.9539 2 0.0 1

HUTSON NANCY J - Director

2021-10-19 16:21:49 -0400 2021-10-15 M 30,000 $5.13 a 125,073 direct 1.9539 1.9539 2 0.0 1

HUTSON NANCY J - Director

2021-10-19 16:21:49 -0400 2021-10-15 M 30,000 d 0 direct

HUTSON NANCY J - Director

2021-10-19 16:21:49 -0400 2021-10-15 M 30,000 $3.22 a 170,073 direct 1.9539 1.9539 2 0.0 1

HUTSON NANCY J - Director

2021-10-19 16:21:49 -0400 2021-10-15 M 30,000 $2.91 a 95,073 direct 1.9539 1.9539 2 0.0 1

HUTSON NANCY J - Director

2021-10-19 16:21:49 -0400 2021-10-15 M 30,000 d 0 direct

HUTSON NANCY J - Director

2021-10-19 16:21:49 -0400 2021-10-15 M 30,000 d 0 direct

HUTSON NANCY J - Director

2021-10-19 16:21:49 -0400 2021-10-15 M 15,000 $1.71 a 140,073 direct 1.9539 1.9539 2 0.0 1

MCKEE AMY E - Director

2021-09-22 16:15:41 -0400 2021-09-20 A 53,333 a 53,333 direct

ABERCROMBIE GEORGE B - Director

2021-09-17 16:31:32 -0400 2021-09-15 M 5,000 d 0 direct

ABERCROMBIE GEORGE B - Director

2021-09-17 16:31:32 -0400 2021-09-15 S 5,000 $15.06 d 0 direct 1.9973 2.3968 2.4634 3 -0.6658 5

ABERCROMBIE GEORGE B - Director

2021-09-17 16:31:32 -0400 2021-09-15 M 5,000 $2.63 a 5,000 direct 1.9973 2.3968 2.4634 3 -0.6658 5

LEE KENNETH B JR - Director

2021-09-15 16:26:43 -0400 2021-09-13 M 15,000 d 0 direct

LEE KENNETH B JR - Director

2021-09-15 16:26:43 -0400 2021-09-13 S 6,000 $15.35 d 24,252 direct 3.2216 1.0519 3.2216 2 -1.2492 3

LEE KENNETH B JR - Director

2021-09-15 16:26:43 -0400 2021-09-13 M 15,000 $3.22 a 30,252 direct 3.2216 1.0519 3.2216 2 -1.2492 3

ABERCROMBIE GEORGE B - Director

2021-09-14 16:14:23 -0400 2021-09-10 M 30,000 d 0 direct

ABERCROMBIE GEORGE B - Director

2021-09-14 16:14:23 -0400 2021-09-10 S 74,000 $15.09 d 0 direct 0.929 2.1234 4.1805 3 -0.3318 4

ABERCROMBIE GEORGE B - Director

2021-09-14 16:14:23 -0400 2021-09-10 M 11,000 $1.71 a 14,000 direct 0.929 2.1234 4.1805 3 -0.3318 4

ABERCROMBIE GEORGE B - Director

2021-09-14 16:14:23 -0400 2021-09-10 M 30,000 d 0 direct

ABERCROMBIE GEORGE B - Director

2021-09-14 16:14:23 -0400 2021-09-10 M 30,000 $2.91 a 74,000 direct 0.929 2.1234 4.1805 3 -0.3318 4

ABERCROMBIE GEORGE B - Director

2021-09-14 16:14:23 -0400 2021-09-10 M 11,000 d 0 direct

ABERCROMBIE GEORGE B - Director

2021-09-14 16:14:23 -0400 2021-09-10 M 30,000 $3.22 a 44,000 direct 0.929 2.1234 4.1805 3 -0.3318 4

GALSON STEVEN K - Director

2021-09-02 16:25:59 -0400 2021-09-01 A 60,000 a 60,000 direct

ASELAGE STEVE - Director

2021-09-02 16:28:26 -0400 2021-08-31 A 314 $15.92 a 32,444 direct -3.576 -1.0856 -4.7254 0.2554 10 -15.0064 21

LEVIN ALAN G - Director

2021-09-02 16:36:23 -0400 2021-08-31 A 628 $15.92 a 628 direct -3.576 -1.0856 -4.7254 0.2554 10 -15.0064 21

HEGGIE THERESA - Director

2021-09-02 16:30:55 -0400 2021-08-31 A 628 $15.92 a 14,794 direct -3.576 -1.0856 -4.7254 0.2554 10 -15.0064 21

INGRAM ROBERT ALEXANDER - Director

2021-09-02 16:33:48 -0400 2021-08-31 A 1,177 $15.92 a 77,378 direct -3.576 -1.0856 -4.7254 0.2554 10 -15.0064 21

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 22:15:03 UTC -0.181 0.251 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 21:45:03 UTC -0.181 0.251 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 21:15:03 UTC -0.181 0.251 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 20:45:03 UTC -0.188 0.258 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 20:15:03 UTC -0.188 0.258 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 19:45:03 UTC -0.188 0.258 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 19:15:03 UTC -0.188 0.258 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 18:45:03 UTC -0.1867 0.2567 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 18:15:03 UTC -0.1867 0.2567 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 17:45:03 UTC -0.1867 0.2567 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 17:15:03 UTC -0.1867 0.2567 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 16:45:03 UTC -0.1888 0.2588 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 16:15:04 UTC -0.1888 0.2588 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 15:45:03 UTC -0.1888 0.2588 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 15:15:03 UTC -0.1888 0.2588 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 14:45:03 UTC -0.199 0.269 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 14:15:03 UTC -0.199 0.269 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 13:45:03 UTC -0.199 0.269 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 13:15:03 UTC -0.199 0.269 2200000
BIOCRYST PHARMACEUTICALS INC BCRX 2021-10-22 12:45:03 UTC -0.199 0.269 2200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund BCRX -9390.0 shares, $-148455.9 2021-06-30 N-PORT
RUSSELL INVESTMENT CO- Sustainable Equity Fund BCRX -7631.0 shares, $-123011.72 2021-07-31 N-PORT
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund BCRX -60557.0 shares, $-976178.84 2021-07-31 N-PORT

Elevate your investments